{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:54:28Z","timestamp":1787788468021,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"crossref","award":["2014\/03\/2048"],"award-info":[{"award-number":["2014\/03\/2048"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ejmech.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T03:30:16Z","timestamp":1452051016000},"page":"247-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents"],"prefix":"10.1016","volume":"109","author":[{"given":"Ahmed M.","family":"Alafeefy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Malek S.","family":"Al-Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al-Obaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla A.","family":"Al-Kahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.01.001_bib1","unstructured":"American cancer Society 2015: http:\/\/www.cancer.org\/cancer\/colonandrectumcancer\/detailedguide\/colorectal-cancer-key-statistics."},{"key":"10.1016\/j.ejmech.2016.01.001_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5306\/wjco.v5.i3.509","article-title":"Preventing breast cancer in LMICs via screening and\/or early detection: the real and the surreal","volume":"10","author":"Day","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2016.01.001_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2174\/092986712799034851","article-title":"Carbonic anhydrase IX as a target for designing novel anticancer drugs","volume":"19","author":"Monti","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.001_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng.3214","article-title":"A\u00a0Big Bang model of human colorectal tumor growth","volume":"47","author":"Sottoriva","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2016.01.001_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(00)79001-4","article-title":"New paradigms for the treatment of cancer: the role of anti- angiogenesis agents","volume":"79","author":"Cherrington","year":"2000","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ejmech.2016.01.001_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm501573b","article-title":"Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties","volume":"22","author":"Bozta\u015f","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"issue":"51","key":"10.1016\/j.ejmech.2016.01.001_bib7","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1021\/jm701526d","article-title":"Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs","volume":"12","author":"Thiry","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.001_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-94-007-7359-2_17","article-title":"Glaucoma and the applications of carbonic anhydrase inhibitors","volume":"75","author":"Scozzafava","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2016.01.001_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2016.01.001_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/13543776.2013.778245","article-title":"Anti-infective carbonic anhydrase inhibitors: a patent and literature review","volume":"23","author":"Capasso","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2016.01.001_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1517\/13543776.2013.777042","article-title":"Metalloenzyme inhibitors for the treatment of gram-negative bacterial infections: a patent review (2009-2012)","volume":"23","author":"Supuran","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2016.01.001_bib12","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1016\/j.bmc.2013.10.007","article-title":"Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2)","volume":"21","author":"Juvale","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.001_bib13","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.ejmech.2010.07.067","article-title":"Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives","volume":"45","author":"Al-Deeb","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.001_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.tetasy.2010.06.012","article-title":"Rhodium-catalysed hydroboration employing new Quinazolinap ligands; an investigation into electronic effects","volume":"21","author":"Maxwell","year":"2010","journal-title":"Tetrahedron Asymmetry"},{"issue":"4","key":"10.1016\/j.ejmech.2016.01.001_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jhet.5570160420","article-title":"Heterocyclic compounds XII. Quinazoline derivatives as potential antifertility agents (1)","volume":"16","author":"Manhas","year":"1979","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2016.01.001_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/14756366.2012.736979","article-title":"Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumor cells in\u00a0vitro","volume":"28","author":"Gieling","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2016.01.001_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotargets"},{"issue":"13","key":"10.1016\/j.ejmech.2016.01.001_bib18","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.bmc.2013.03.068","article-title":"Hypoxia induced CA9 inhibitory targeting by two different sulphonamide derivatives including Acetazolamide in human glioblastoma","volume":"21","author":"Said","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2016.01.001_bib19","first-page":"4469","article-title":"Lowered oxygen tension induces expression of the hypoxia marker MN\/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3\u2032-kinase","volume":"62","author":"Kaluz","year":"2002","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2016.01.001_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbaexp.2005.03.003","article-title":"MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX","volume":"1729","author":"Kopacek","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"24","key":"10.1016\/j.ejmech.2016.01.001_bib21","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.01.001_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ncb1661","article-title":"MUC1 oncoprotein activates the IkB kinase \u03b2 complex and constitutive NF-kB signaling","volume":"9","author":"Ahmad","year":"2007","journal-title":"Nat. Cell Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416300010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416300010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T16:19:27Z","timestamp":1600013967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416300010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":22,"alternative-id":["S0223523416300010"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.001","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}